PLK1-IN-17
PLK1-IN-17 is a potent PLK1 inhibitor with an IC50 of 2 nM. PLK1-IN-17 shows high selectivity for PLK2 and CDK2/A, moderate selectivity for PLK3, only weak activity against CK2, FLT3 and NEK6, and no activity against PDGFR, ALK and another 37 kinases. PLK1-IN-17 inhibits the proliferation of ovarian cancer cells and can be used in ovarian cancer-related research.
For research use only. We do not sell to patients.
- CAS No.: 1034617-66-7
- Formula: C22H23F3N8O2
- Molecular Weight:488.47
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
PLK1 2 nM (IC50) |
FLT3 194 nM (IC50) |
CK2 59 nM (IC50) |
NEK6 595 nM (IC50) |
PLK1-IN-17 potently inhibits recombinant PLK1 with an IC50 of 0.002 μM, while showing high selectivity over PLK2, CDK2/A, and moderate selectivity over PLK3[1].
PLK1-IN-17 potently inhibits PLK1 with an IC50 of 0.002 μM, shows weak activity against CK2, FLT3, and NEK6, and is inactive against PDGFR, ALK, and 37 additional tested kinases[1].
PLK1-IN-17 inhibits A2780 ovarian carcinoma cell proliferation with an IC50 of 0.03 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1034617-66-7
-
Molecular Weight 488.47
-
Formula C22H23F3N8O2
-
SMILES
O=C(C1=NN(C)C2=C1CCC3=C2N=C(NC4=CC(N5CCNCC5)=CC=C4OC(F)(F)F)N=C3)N
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)